Our product aims to stem uncontrolled blood loss on the battlefield. Nearly a quarter of the 4,596 combat deaths in Iraq and Afghanistan between 2001 and 2011 were “potentially survivable.” [1]. Uncontrolled blood loss was the leading cause of death in 90% of the potentially survivable battlefield cases [1]. And in 80% of those cases, the wounded patient died in a military treatment facility [1]. That’s over a thousand sons and daughters who never came back to their families. Our product intends to reduce that number significantly. Our goal was to create a cost effective, chitosan based wound dressing material with inherent microbicidal properties and oxygen releasing to create a non-toxic protective barrier with greatly enhanced bacterial and fungal resistance. We were focused on stopping the most common and deadly hospital acquired infection, methicillin-resistant staphylococcus aureus (MRSA) [2 ]. MRSA is highly adaptable and very resistant to antibiotics so we focused on alternative Microbicidal Agents [3].